Merit Medical Systems Inc (MMSI, Financial) is set to release its Q3 2024 earnings on Oct 30, 2024. The consensus estimate for Q3 2024 revenue is $334.62 million, and the earnings are expected to come in at $0.48 per share. The full year 2024's revenue is expected to be $1.34 billion and the earnings are expected to be $2.11 per share. More detailed estimate data can be found on the Forecast page.
Merit Medical Systems Inc (MMSI, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Merit Medical Systems Inc (MMSI) for the full year 2024 have increased from $1.33 billion to $1.34 billion and from $1.42 billion to $1.46 billion for 2025. Earnings estimates for the full year 2024 have declined from $2.15 per share to $2.11 per share, and from $2.63 per share to $2.57 per share for 2025.
Merit Medical Systems Inc (MMSI, Financial) Reported History
In the previous quarter of 2024-06-30, Merit Medical Systems Inc's (MMSI) actual revenue was $338 million, which beat analysts' revenue expectations of $334.55 million by 1.03%. Merit Medical Systems Inc's (MMSI) actual earnings were $0.61 per share, which beat analysts' earnings expectations of $0.60 per share by 2.52%. After releasing the results, Merit Medical Systems Inc (MMSI) was up by 5.49% in one day.
Merit Medical Systems Inc (MMSI, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 11 analysts, the average target price for Merit Medical Systems Inc (MMSI) is $108.91 with a high estimate of $125 and a low estimate of $94. The average target implies an upside of 14.27% from the current price of $95.31.
Based on GuruFocus estimates, the estimated GF Value for Merit Medical Systems Inc (MMSI, Financial) in one year is $86.57, suggesting a downside of -9.17% from the current price of $95.31.
Based on the consensus recommendation from 11 brokerage firms, Merit Medical Systems Inc's (MMSI, Financial) average brokerage recommendation is currently 1.8, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
